Clinical Trials Browser

Phase 2 × NETWORK × Carcinoma, Medullary × Clear all

NCT01788982 2020-07-31

Nintedanib(BIBF1120) in Thyroid Cancer

Phase 2 Completed

Thyroid Neoplasms, Carcinoma, Medullary

NCT01736878 2013-05-17

SUMMIT

Phase 2 Withdrawn

Carcinoma, Medullary